User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.

Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Reneuron Group Plc LSE:RENE London Ordinary Share GB00BF5G6K95 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.67% 147.50 145.00 150.00 149.50 147.50 149.50 68,911 16:09:39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 6.1 -13.9 -35.9 - 84

Reneuron Share Discussion Threads

Showing 8101 to 8124 of 8300 messages
Chat Pages: 332  331  330  329  328  327  326  325  324  323  322  321  Older
DateSubjectAuthorDiscuss
05/1/2021
13:46
Analyst conference call and webcast A conference call for analysts will be held at 10.00 a.m. on 6 January 2021 to discuss the Company’s recent half year results, the fundraising and outlook for the year ahead. Analysts who require dial-in details please contact Buchanan at reneuron@buchanan.uk.com. A recorded webcast of the analyst conference call, including investor presentation slides, will be made available during the afternoon of 6 January 2021 at this link: htTps://webcasting.buchanan.uk.com/broadcast/5fd23c59ca22cd76f9d3c662 The recorded webcast will also be made available at the investor centre of ReNeuron’s website, htTp://www.reneuron.com/investors/investor-centre/.
dontshootthemessenger
05/1/2021
13:41
Setting up very nicely going into tomorrow. Not expecting any fireworks just the prepping of the Analysts for the nature and scope of the upcoming fireworks some of which may be displayed at JPM Healthcare Conference or at least timed to coincide with it
dontshootthemessenger
05/1/2021
08:17
Click on 'stock entry details' on the bottom tab, then click on 'selected by' on the column headings to sort. That will show you XAR is the most popular.
v11slr
04/1/2021
14:05
i only need 1135 to break even... :-(
stewart_25
04/1/2021
12:50
You are not alone Bob. RENE is one of my naps for 2021.
sspurt
04/1/2021
10:51
htTps://twitter.com/Stockonomist/status/1346045967083184129?s=20
the stigologist
04/1/2021
10:37
Thanks for the link No one seems interested on advfn.
bobdown2
04/1/2021
10:31
hTTps://twitter.com/sharesearch_/status/1346017118630895616
xow98
04/1/2021
10:20
On a chart above the red line has moved above the blue.. the first time for a while. I would take it as a positive. Some would say I am ramping.. I would call it attention seeking. I have bought into the rise and like the buying level.
bobdown2
04/1/2021
10:16
At the moment it is small sells and another 20k buy.
bobdown2
04/1/2021
10:05
This rise has gone unnoticed.. I've bought between 90 and 95.5.. that's enough.. the larger sized trades that went through maybe showing the way. It's close to the bottom of its trading range which is a good place to buy..
bobdown2
04/1/2021
09:37
I wonder if there will be news released on Jan 6 to coincide with analyst meeting. Could they release the first 3 months numbers on the expanded trial with the higher dose? I am impressed that the 12 month numbers showed sustained improvement. It is the reason I am a holder and there is certainly potential for improved VA at the higher dose.
pdt
04/1/2021
08:58
Good start ahead of Wednesday Analyst Day
the stigologist
23/12/2020
15:10
The analyst conference is on Jan 6 which should be a further catalyst.
onceaday
23/12/2020
14:48
Could be about to see a very strong finish
diversification
18/12/2020
08:48
Yep. His timing was spot on last time.
onceaday
18/12/2020
07:27
Griffiths ups stake to 5%
ayl30
17/12/2020
11:03
There is an analyst meeting on Jan 6. I imagine they will crank up the PR machine after that.
onceaday
17/12/2020
10:49
Isn't there a City convention about not publishing research on a deal within 2 weeks of it going live or something ? So we should see some research coverage and target price upgrade soon ?
the stigologist
17/12/2020
07:39
Commenting on the notification of allowance, Olav Hellebø, Chief Executive Officer of ReNeuron, said:"We are delighted to have received this latest US notice of allowance to add to ReNeuron's extensive patent estate of over 250 patents across 29 patent families encompassing all of its technologies and therapeutic candidates. This patent, together with the earlier patent granted in July, adds significant value to our hRPC patent estate, supporting our aim to secure future high value out-licensing deals for our retinal disease programme."
jpuff
17/12/2020
07:19
RNS - ReNeuron Group plc Notification of Allowance granted for US Patent.Great news!
jpuff
16/12/2020
18:45
Is it not just dilution from placing?
harrywilliam
16/12/2020
18:37
Perhaps it has been responsible for decline since October and is now finished?
small crow
16/12/2020
18:23
Agree smallcrow - a bit worrying that the Wales Life Sciences Investment Fund have halved.
rotors
Chat Pages: 332  331  330  329  328  327  326  325  324  323  322  321  Older
ADVFN Advertorial
Your Recent History
LSE
RENE
Reneuron
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210509 23:06:20